GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9384243)

Published in Eur J Pharmacol on October 08, 1997

Authors

T Mennini1, L Mancini, A Reggiani, D Trist

Author Affiliations

1: Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. tiziana@irfmn.mnegri.it

Articles by these authors

Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature (1994) 3.33

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci (2006) 1.80

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63

Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance. Dig Liver Dis (2009) 1.39

In silico research in drug discovery. Trends Pharmacol Sci (2001) 1.36

[A longitudinal entomologic survey on the transmission of malaria in Ouagadougou (Burkina Faso)]. Parassitologia (1986) 1.30

Pseudoaneurysm as a complication of ankle arthroscopy. Arthroscopy (2001) 1.17

Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16

Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med (2010) 1.15

New features of dislocation images in third-generation synchrotron radiation topographs. J Synchrotron Radiat (1996) 1.12

Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder. Br J Pharmacol (1991) 1.06

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04

Monitoring of the heavy-metal hyperaccumulation in vegetal tissues by X-ray radiography and by femto-second laser induced breakdown spectroscopy. Microsc Res Tech (2007) 1.03

The continuing evolution of the drug discovery process in the pharmaceutical industry. Farmaco (2001) 1.01

Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98

C-reactive protein and erythrocyte sedimentation rate changes following arthroscopically assisted anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc (2001) 0.97

Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol (2009) 0.97

Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations. Arch Dis Child (1985) 0.97

Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br J Pharmacol (2009) 0.96

The microvascular system in ischemic cortical lesions. Acta Neuropathol (1996) 0.94

High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage (2011) 0.93

Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier. Br J Pharmacol (2012) 0.92

Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). Int J Mol Med (2002) 0.91

Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer (1992) 0.91

Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus. J Pharmacol Exp Ther (1992) 0.91

Mortality from liver disease among Italian vinyl chloride monomer/polyvinyl chloride manufacturers. Am J Ind Med (1990) 0.91

Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades. J Urol (1989) 0.90

The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Exp Neurol (1997) 0.90

Effects of the metabotropic glutamate receptor antagonist MCPG on spatial and context-specific learning. Neuropharmacology (1996) 0.90

Qualitative and quantitative analysis of the progressive cerebral damage after middle cerebral artery occlusion in mice. Brain Res (1993) 0.87

Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists. J Med Chem (2000) 0.86

[The mortality among the makers of vinyl chloride in Italy]. Med Lav (1992) 0.86

1H-NMR and 13C-NMR lipid profiles of human renal tissues. Biopolymers (2003) 0.86

Ewing's sarcoma of the mandible and maxilla. A report of three cases from the Istituto Beretta. Oral Surg Oral Med Oral Pathol (1986) 0.85

Dopamine metabolism and receptor function after acute and chronic ethanol. J Neurochem (1980) 0.84

Pharmacological analysis of carboxyphenylglycines at metabotropic glutamate receptors. Eur J Pharmacol (1994) 0.84

Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem (1997) 0.84

Regulation of synaptic plasticity by mGluR1 studied in vivo in mGluR1 mutant mice. Brain Res (1997) 0.83

Cholesteryl esters in human malignant neoplasms. Int J Mol Med (2003) 0.82

Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1. Childs Nerv Syst (1993) 0.82

Magnetic resonance spectroscopy and chromatographic methods identify altered lipid composition in human renal neoplasms. Int J Mol Med (2004) 0.81

[On the mechanism of the mucolytic action of N-acetyl-L-cysteine]. Boll Soc Ital Biol Sper (1965) 0.81

Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. J Pharmacol Exp Ther (1999) 0.81

Microscopical and ultrastructural investigations on the development of the blood-brain barrier in the chick embryo optic tectum. Acta Neuropathol (1986) 0.81

L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int (2005) 0.81

A cohort study on vinyl chloride manufacturers in Italy: study design and preliminary results. Cancer Lett (1987) 0.80

Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study. Eur J Pediatr (1993) 0.80

Nationwide pseudo-outbreak of Salmonella enterica ssp. diarizonae, France. Clin Microbiol Infect (2010) 0.80

Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract (1992) 0.80

Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology (Berl) (1990) 0.80

The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behav Pharmacol (2002) 0.80

[Respiratory functional changes in subjects exposed to chromium. I. Spirographic changes]. Lav Um (1973) 0.80

Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia. Eur J Pharmacol (1992) 0.79

[Effects of chronic hypoxia on microcirculation of the central nervous system during embryonic development]. Boll Soc Ital Biol Sper (1984) 0.79

Influence of age on oxidative bursts (chemiluminescence) of polymorphonuclear neutrophil leukocytes. Gerontology (1998) 0.79

Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.79

Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy. Horm Metab Res (2008) 0.79

Domoic acid toxicity in rats and mice after intracerebroventricular administration: comparison with excitatory amino acid agonists. Pharmacol Toxicol (1992) 0.79

Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids. Dig Liver Dis (2003) 0.79

Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. J Neurochem (1999) 0.78

Permeability-related structures in developing and mature microvessels of the chicken optic tectum. Biol Struct Morphog (1992) 0.78

Effects of nedocromil sodium on the oxidative burst of polymorphonuclear leukocytes: comparison with salbutamol. Drugs Exp Clin Res (1997) 0.78

Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice. J Neurol Sci (1998) 0.78

L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice. Calcif Tissue Int (2008) 0.77

Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer. Breast Cancer Res Treat (1990) 0.77

Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report. Transplant Proc (2008) 0.77

Acute and chronic ethanol administration on specific 3H-GABA binding in different rat brain areas. Psychopharmacology (Berl) (1980) 0.77

Involvement of monoaminergic and peptidergic components in cathinone-induced analgesia. Eur J Pharmacol (1985) 0.77

Effect of inhibition of neuropeptidases on the pain threshold of mice and rats. Neuropharmacology (1983) 0.77

Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands. Expert Opin Investig Drugs (2000) 0.77

The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats. Eur J Pharmacol (1999) 0.77

Pulmonary hypertension as a predictor of postoperative complications and mortality after liver transplantation. Transplant Proc (2010) 0.77

Angiogenesis and endothelium phenotype expression in embryonic adrenal gland and cerebellum grafted onto chorioallantoic membrane. Angiogenesis (1999) 0.76

Can voltammetry measure nitrogen monoxide (NO) and/or nitrites? J Neurosci Methods (2001) 0.76

Ethanol-induced changes of dopaminergic function in three strains of mice characterized by a different population of opiate receptors. Psychopharmacology (Berl) (1981) 0.76

Correlation MRI/ultrastructure in cerebral ischemic lesions: application to the interpretation of cortical layered areas. Magn Reson Imaging (2002) 0.76

Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients. Minerva Med (2006) 0.76

Elastic modulus in young diabetic patients (ultrasound measurements of pulse wave velocity). Angiology (1984) 0.76

Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia. J Med Chem (1999) 0.76

Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia. Eur J Pharmacol (1984) 0.76

Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus. Br J Pharmacol (1993) 0.76

Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients. Int Angiol (1989) 0.76

Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine. Brain Res (1996) 0.76

Pachydermoperiostosis: dermatological, neurological and radiological observations. Clin Rheumatol (1995) 0.75

Gastric emptying rate and hormonal response in type II diabetics. Diabetes Res (1991) 0.75

Computerized three-dimensional reconstruction of the developing blood-brain barrier. Acta Neuropathol (1989) 0.75

Process of differentiation of cerebellar Purkinje neurons in the chick embryo. Anat Embryol (Berl) (1986) 0.75

Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes. Chemotherapy (1999) 0.75

Ultrastructure and permeability of immature neural and extraneural blood vessels. Biol Struct Morphog (1991) 0.75

[Importance of the vasa vasorum in the healing processes of arterial sutures. (Experimental study on the dog)]. Boll Soc Ital Biol Sper (1967) 0.75

The barrier systems in the choroidal plexuses of the chick embryo studied by means of horseradish peroxidase. J Submicrosc Cytol Pathol (1988) 0.75

[Effects of digitalis on the left ventricular filling phase in the normal and ischemic heart. Angiographic study in man]. Cardiologia (1989) 0.75

[Echographic diagnosis of Peyronie's disease]. Radiol Med (1989) 0.75

[Experimental research on resections and anastomoses of the bronchi. II. Behavior of the bronchial arteries]. Boll Soc Ital Biol Sper (1968) 0.75

[Respiratory functional changes in subjects exposed to chromium. II. Steady-state CO transfer changes]. Lav Um (1973) 0.75

New isoxazole derivatives provided with antihypertensive activity. Arzneimittelforschung (1989) 0.75

[Safety forms for industrial lubricating oils: a working proposal at the national level]. Med Lav (1990) 0.75

[Indications for binephrectomy. Surgical technics and results]. Minerva Nefrol (1975) 0.75

Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation. Drugs Exp Clin Res (1988) 0.75